Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
HLGN.WS
HLGN.WS was delisted on the 7th of November, 2023.
17 hedge funds and large institutions have $7M invested in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 14 closing their positions.
24% less capital invested
Capital invested by funds: $9.17M → $7M (-$2.17M)
39% less funds holding
Funds holding: 28 → 17 (-11)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
79% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
+$638K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
+$413K |
| 3 |
CCP
Corbin Capital Partners
New York
|
+$341K |
| 4 |
JG
Jefferies Group
New York
|
+$18.4K |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$13.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$639K |
| 2 |
SBLIC
Security Benefit Life Insurance Company
Topeka,
Kansas
|
-$555K |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$438K |
| 4 |
LA
Linden Advisors
New York
|
-$429K |
| 5 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$428K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ICMH
26
Integrity Capital Management (HK)
Central,
Hong Kong
| – | -$85K | -50,000 | Closed |
|
|
HI
27
HBK Investments
Dallas,
Texas
| – | -$77K | -45,100 | Closed |
|
28
Walleye Capital
New York
| – | -$69K | -40,545 | Closed |
|
29
Bank of America
Charlotte,
North Carolina
| – | -$42K | -25,000 | Closed |
|
|
VF
30
Virtu Financial
New York
| – | -$27K | -15,921 | Closed |
|
|
WAM
31
Wolverine Asset Management
Chicago,
Illinois
| – | -$2K | -1,500 | Closed |
|
|
HNB
32
Huntington National Bank
Columbus,
Ohio
| – | -$156 | -160 | -32% |
|
HLGN.WS Hedge Fund Activity: Q1 2022 in Review
17 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) for Q1 2022, worth a combined $7M — down 24% from $9.17M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of HLGN.WS and 3 opened new positions — a net loss of 11 holders — while 6 trimmed existing stakes and 2 added.
The largest buyer was Privium Fund Management, opening a new position worth an estimated $638K. The largest seller was AQR Arbitrage, exiting entirely with an estimated $639K sold.
- 17 institutional investors held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) as of Q1 2022, down from 28 in Q4 2021.
- Funds reported $7M of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 stock for Q1 2022, down 24% quarter-over-quarter.
- 3 funds opened new Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 positions in Q1 2022 and 14 closed out, a net change of -11 holders.
- The largest Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 buyer in Q1 2022 was Privium Fund Management, an estimated $638K added.
- The largest Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 seller in Q1 2022 was AQR Arbitrage, an estimated $639K sold.
Based on aggregated 13F filings for Q1 2022.